Protara Therapeutics (TARA) Interest Expenses (2013 - 2019)

Protara Therapeutics' Interest Expenses history runs 7 years deep, the most recent figure standing at $59000.0 for Q4 2019.

• In Q4 2019, Interest Expenses fell 65.09% year-over-year to $59000.0; the TTM figure through Dec 2019 stood at $59000.0 (down 65.09% YoY), while the FY2019 annual figure was $59000.0, down 65.09% from the prior year.
• Interest Expenses was $59000.0 for Q4 2019 at Protara Therapeutics, down from $169000.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $52.2 million in Q4 2015 to a low of $59000.0 in Q4 2019.
• Historically, Interest Expenses has averaged $8.7 million across 5 years, with a median of $600000.0 in 2017.
• The sharpest annual moves came in 2015 and 2016: Interest Expenses soared 401700.0% in 2015, then tumbled 99.39% in 2016.
• A 5-year view of Interest Expenses shows it stood at $52.2 million in 2015, then sank by 99.39% to $321000.0 in 2016, then surged by 2064.8% to $6.9 million in 2017, then slumped by 97.57% to $169000.0 in 2018, then tumbled by 65.09% to $59000.0 in 2019.
• The last three Interest Expenses figures came in at $59000.0 (Q4 2019), $169000.0 (Q4 2018), and $6.9 million (Q4 2017), per Business Quant data.